IL40376A0 - Pharmaceutical compositions containing an estrogenic and a progestational substance - Google Patents

Pharmaceutical compositions containing an estrogenic and a progestational substance

Info

Publication number
IL40376A0
IL40376A0 IL40376A IL4037672A IL40376A0 IL 40376 A0 IL40376 A0 IL 40376A0 IL 40376 A IL40376 A IL 40376A IL 4037672 A IL4037672 A IL 4037672A IL 40376 A0 IL40376 A0 IL 40376A0
Authority
IL
Israel
Prior art keywords
estrogenic
pharmaceutical compositions
compositions containing
progestational substance
progestational
Prior art date
Application number
IL40376A
Other languages
English (en)
Original Assignee
Biolog Concepts Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolog Concepts Inc filed Critical Biolog Concepts Inc
Publication of IL40376A0 publication Critical patent/IL40376A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL40376A 1972-02-22 1972-09-15 Pharmaceutical compositions containing an estrogenic and a progestational substance IL40376A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00228365A US3836651A (en) 1972-02-22 1972-02-22 Novel oral contraceptive combination

Publications (1)

Publication Number Publication Date
IL40376A0 true IL40376A0 (en) 1972-11-28

Family

ID=22856883

Family Applications (1)

Application Number Title Priority Date Filing Date
IL40376A IL40376A0 (en) 1972-02-22 1972-09-15 Pharmaceutical compositions containing an estrogenic and a progestational substance

Country Status (7)

Country Link
US (1) US3836651A (xx)
AU (1) AU463937B2 (xx)
DE (1) DE2253916A1 (xx)
FR (1) FR2172953B1 (xx)
GB (1) GB1343595A (xx)
IL (1) IL40376A0 (xx)
ZA (1) ZA726265B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982004230A1 (en) * 1981-05-29 1982-12-09 Orion Solotar Improvements in or relating to forklifts
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US5010070A (en) * 1987-06-15 1991-04-23 Warner-Lambert Company Graduated estrogen contraceptive
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
WO1988007056A1 (en) * 1987-03-10 1988-09-22 Eastern Virginia Medical Authority METHOD AND KIT FOR CONTRACEPTION WITH GnRH-ANTAGONIST AND PROGESTIN
US5116818A (en) * 1987-03-10 1992-05-26 Medical College Of Hampton Roads Method and kit for contraception with GnRH-antagonist
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
NO301689B1 (no) * 1987-09-24 1997-12-01 Jencap Research Ltd Kontraseptivt preparat i form av en forpakning
US5116865A (en) * 1990-09-05 1992-05-26 Peters Richard H 15,16-seco-19-nor progestins
US5433219A (en) * 1992-09-23 1995-07-18 Spery; Nanette S. Receptive condom assembly
US6214815B1 (en) 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US6660726B2 (en) * 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
JP2004140323A (ja) * 2002-08-20 2004-05-13 Sharp Corp 半導体レーザ装置およびその製造方法
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins

Also Published As

Publication number Publication date
FR2172953A1 (xx) 1973-10-05
ZA726265B (en) 1973-06-27
US3836651A (en) 1974-09-17
DE2253916A1 (de) 1973-09-06
AU463937B2 (en) 1975-08-07
AU4670472A (en) 1974-03-21
GB1343595A (en) 1974-01-10
FR2172953B1 (xx) 1975-10-31

Similar Documents

Publication Publication Date Title
IL40376A0 (en) Pharmaceutical compositions containing an estrogenic and a progestational substance
IL42430A0 (en) Pyridopyrrolobenzheterocycles,their preparation and pharmaceutical compositions containing them
IL43762A (en) 11,11-alkylidene-steroids their preparation and pharmaceutical compositions containing them
PH10338A (en) Steroid formulation
ZA731808B (en) Pharmaceutical compositions
KE2853A (en) Pharmaceutical composition
IL43837A0 (en) New aminophenyl-ethanolamines and corresponding oxazolidines,their preparation and pharmaceutical compositions containing them
ZA733406B (en) Pharmaceutical formulations
IL43722A0 (en) Novel 2-aminomethyleneindanones and pharmaceutical compositions containing them
IL42429A0 (en) 2-alkoxycephalosporins,their preparation and pharmaceutical compositions containing them
IL43766A0 (en) Pharmaceutical compositions containing bis-phenolalkane derivatives
IL42384A0 (en) N-benzhydryl-n'-p-hydroxybenzyl-piperazines and processes for their manufacture and pharmaceutical compositions containing them
PH11231A (en) Piperidinesulfonylurea derivatives and pharmaceutical compositions containing them
AU5731773A (en) 2-oxo-indoline compounds and pharmaceutical compositions
IE39291B1 (en) Pharmaceutical compositions comprising an anzyme and substtrate
IL41512A0 (en) New oxazoles,their preparation and pharmaceutical compositions containing them
IL42790A0 (en) 4a-aryl-trans-decahydroisoquino-lines,their preparation and pharmaceutical compositions containing them
IL40747A (en) 1-phenyl-3-hydroxy-3-methyltriazenes,their preparation and pharmaceutical compositions containing them
IL42613A0 (en) Amino-imidazo-and amino-pyrazolo-isoquinolines,their preparation and pharmaceutical compositions containing them
ZA745114B (en) A medicament- thiazole 5-methanol and pharmaceutical compositions containing
ZA731012B (en) Pharmaceutical compositions
ZA738187B (en) Pharmaceutical composition and preparation thereof
ZA732439B (en) Pharmaceutical composition
IL43030A0 (en) Pharmaceutical compositions containing a benzodiazepine and a benzamide derivative
KE2807A (en) Pharmaceutical formulations